Suppr超能文献

根据能力验证和外部质量评估调查,在西格玛量表上评估质量。

Assessing quality on the Sigma scale from proficiency testing and external quality assessment surveys.

作者信息

Westgard James O, Westgard Sten A

出版信息

Clin Chem Lab Med. 2015 Sep 1;53(10):1531-5. doi: 10.1515/cclm-2014-1241.

Abstract

BACKGROUND

There is a need to assess the quality being achieved for laboratory examinations that are being utilized to support evidence-based clinical guidelines. Application of Six Sigma concepts and metrics can provide an objective assessment of the current analytical quality of different examination procedures.

METHODS

A "Sigma Proficiency Assessment Chart" can be constructed for data obtained from proficiency testing and external quality assessment surveys to evaluate the observed imprecision and bias of method subgroups and determine quality on the Sigma scale.

RESULTS

Data for hemoglobin A1c (HbA1c) from a 2014 survey by the College of American Pathologists (CAP) demonstrates that approximately two-thirds of the examination subgroups provide only two-Sigma quality when evaluated against the CAP requirement of an allowable total error of 6.0%. The weighted averages were 1.46 Sigma for a survey sample with an assigned value of 6.49% Hb (average bias 2.31%, CV 2.87%), 1.45 Sigma at 6.97% Hb (average bias 2.29%, CV 2.81%), and 1.75 at 9.65% Hb (average bias 1.55%, CV 2.71%). Maximum biases for examination subgroups were 5.7%, 5.8%, and 4.1%, respectively.

CONCLUSIONS

Assessment of quality on the Sigma scale provides evidence of the analytical performance that is being achieved relative to requirements for intended use and should be useful for identifying and prioritizing improvements that are needed in the analytical quality of laboratory examinations. In spite of global and national standardization programs, bias is still a critical limitation of current HbA1c examination procedures.

摘要

背景

需要评估用于支持循证临床指南的实验室检查所达到的质量。应用六西格玛概念和指标可以对不同检查程序当前的分析质量进行客观评估。

方法

可以根据能力验证和外部质量评估调查获得的数据构建一个“西格玛能力评估图”,以评估方法亚组观察到的不精密度和偏差,并在西格玛尺度上确定质量。

结果

美国病理学家协会(CAP)2014年一项调查中血红蛋白A1c(HbA1c)的数据表明,当根据CAP规定的6.0%允许总误差进行评估时,约三分之二的检查亚组仅提供二西格玛质量。对于赋值为6.49%血红蛋白(平均偏差2.31%,变异系数2.87%)的调查样本,加权平均值为1.46西格玛;对于6.97%血红蛋白的样本,为1.45西格玛(平均偏差2.29%,变异系数2.81%);对于9.65%血红蛋白的样本,为1.75西格玛(平均偏差1.55%,变异系数2.71%)。检查亚组的最大偏差分别为5.7%、5.8%和4.1%。

结论

在西格玛尺度上进行质量评估可提供相对于预期用途要求所达到的分析性能的证据,并且对于识别实验室检查分析质量所需改进并确定其优先级应是有用的。尽管有全球和国家标准化计划,但偏差仍是当前HbA1c检查程序的一个关键限制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验